2019 MENACTRIMS MS Diagnosis and Treatment Guidelines
Published on Fri, 18 Oct 2019

Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines
The 2019 MENACTRIMS guidelines offer revised diagnostic and treatment recommendations for multiple sclerosis (MS) to reflect advancements in diagnostic criteria and therapies. Diagnosis emphasizes proving dissemination in space and time while excluding alternative explanations, guided by clinical and laboratory findings. Treatment algorithms address acute relapses, radiologically isolated syndrome, clinically isolated syndrome, relapsing-remitting MS, and progressive MS. These practical, evidence-based guidelines aim to improve patient outcomes through informed diagnostic and therapeutic decisions.